Getinge AB Series B | |
Stock Exchange | Other OTC |
EPS |
$0.27 |
Market Cap |
$4 B |
Shares Outstanding |
222.38 M |
Public Float |
- |
Getinge AB ADR | |
Stock Exchange | Other OTC |
EPS |
$0.27 |
Market Cap |
$3.89 B |
Shares Outstanding |
254.15 M |
Public Float |
- |
Getinge AB Series B | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
254.15 M |
Public Float |
- |
Getinge AB Series B | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK2.4 |
Market Cap |
SEK39.49 B |
Shares Outstanding |
254.15 M |
Public Float |
217.5 M |
Address |
Lindholmspiren 7A Gothenburg VG 417 56 Sweden |
Employees | - |
Website | http://www.getingegroup.com |
Updated | 07/08/2019 |
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It operates through the following segments: Acute Care Therapies, Surgical Workflows, and Group Functions. The Acute Care Therapies segment offers solutions for life support in acute health conditions which includes solutions for cardiac, pulmonary and vascular therapies and a broad selection of products and therapies for intensive care. |